KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $7.7 million.

  • Exact Sciences' Treasury Shares rose 224.57% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 224.57%. This contributed to the annual value of $7.2 million for FY2024, which is 1549.61% up from last year.
  • Latest data reveals that Exact Sciences reported Treasury Shares of $7.7 million as of Q3 2025, which was up 224.57% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Treasury Shares ranged from a high of $8.4 million in Q1 2025 and a low of $4.3 million during Q3 2021
  • Its 5-year average for Treasury Shares is $6.4 million, with a median of $6.4 million in 2023.
  • In the last 5 years, Exact Sciences' Treasury Shares tumbled by 748.51% in 2021 and then skyrocketed by 3494.04% in 2022.
  • Over the past 5 years, Exact Sciences' Treasury Shares (Quarter) stood at $4.3 million in 2021, then increased by 21.61% to $5.3 million in 2022, then grew by 19.37% to $6.3 million in 2023, then rose by 15.5% to $7.2 million in 2024, then grew by 5.66% to $7.7 million in 2025.
  • Its Treasury Shares was $7.7 million in Q3 2025, compared to $8.1 million in Q2 2025 and $8.4 million in Q1 2025.